Atracurium Besylate
Specifications
64228-81-5CAS Number
264-743-4EC Number
benzenesulfonate;5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoateIUPAC Name
C65H82N2O18S2Chemical Formula
1243.5 g/molMolecular Weight
Atracurium besylate; 64228-81-5; Atracurium besilate; Atracurium Dibesylate; Besilate d'atracurium; Besilato de atracurio; Atracurii besilas; BW 33A; BW-33A; Tracrium Preservative Free; DTXSID6022630; Atracurium Besylate Preservative Free; benzenesulfonate;5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate; NSC-760047; WELLCOME 33-A-74; CHEBI:2915; DTXCID302630; 40AX66P76P; atracurio besilato; benzenesulfonate;5-(3-(1-((3,4-dimethoxyphenyl)methyl)-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl)propanoyloxy)pentyl 3-(1-((3,4-dimethoxyphenyl)methyl)-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl)propanoate; atracurium (cation); Besilate, Atracurium; RefChem:56877; BW33A; M03AC04; 264-743-4; Tracrium; Atracurium (besylate); 2,2'-((pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium) benzenesulfonate; 2,2'-[1,5-PENTANEDIYLBIS[OXY(3-OXO-3,1-PROPANEDIYL)]]BIS[1-[(3,4-DIMETHOXYPHENYL)METHYL]-1,2,3,4-TETRAHYDRO-6,7-DIMETHOXY-2-METHYL-ISOQUINOLINIUM DIBENZENESULFONATE; C65H82N2O18S2; MFCD00797403; Atracurium besilate (INN); Atracurium besilate [INN]; Atracurium Besylate (cis-Monoquatenary); Atracurii besilas [INN-Latin]; BW 33 A; Besilate d'atracurium [INN-French]; EINECS 264-743-4; Besilato de atracurio [INN-Spanish]; UNII-40AX66P76P; Atracurium besylate [USAN:USP]; NCGC00017127-01; Tracrium (TN); 33 A 74; CAS-64228-81-5; Atracurium besilate CRS; Atracurium besylate (USP); SCHEMBL41251; 2-(2-Carboxyethyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-veratrylisoquinolinium benzenesulfonate, pentamethylene ester; Pentamethylen bis(3-(1,2,3,4-tetrahydro-6,7-dimethoxy-1-(3,4-dimethoxybenzyl)-2-methyl-2-isochinolyl)propionat) bis(benzolsulfonat); HY-B0292AR; orb1300803; CHEMBL1200527; SCHEMBL30753552; HY-B0292A; Atracurium (besylate) (Standard); GLXC-06200; HMS1568A11; HMS2095A11; HMS3651C21; HMS3712A11; HMS3884G12; HMS5080G13; HMS5080I12; Pharmakon1600-01505872; Tox21_110790; EBC-27542; NSC760047; s1832; AKOS015895831; Atracurium for peak identification CRS; AB07163; CCG-213566; DB00732; FA18027; NC00429; NSC 760047; NCGC00262598-01; NCGC00262598-02; 2,2'-[1,5-Pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methylisoquinolinium] Dibenzenesulfonate; AS-14131; Isoquinolinium, 2,2'-(1,5-pentanediylbis(oxy(3-oxo-3,1-propanediyl)))bis(1-((3,4-dimethoxyphenyl)methyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, dibenzenesulfonate; A2566; A7668; Atracurium for impurity F identification CRS; NS00086140; SW197148-4; T6397; Atracurium besylate, >=98% (HPLC), powder; D00758; EN300-297373; F556525; Q165660; SR-01000781272; SR-01000781272-3; Atracurium besylate, European Pharmacopoeia (EP) Reference Standard; Atracurium besylate, United States Pharmacopeia (USP) Reference Standard; Atracurium for impurity F identification, European Pharmacopoeia (EP) Reference Standard; Atracurium for peak identification, European Pharmacopoeia (EP) Reference Standard; 1-[(3,4-dimethoxyphenyl)methyl]-2-[3-({5-[(3-{1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-2-yl}propanoyl)oxy]pentyl}oxy)-3-oxopropyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium dibenzenesulfonate; 2,2'-((pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium)benzenesulfonate; 2,2'-[1,5-Pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-i soquinolinium benzenesulfonate; 2,2'-{1,5-Pentanediylbis[oxy(3-oxo-3,1-propanediyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium dibenzenesulphonate; 2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate; 2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-{[3,4-bis(methyloxy)phenyl]methyl}-2-methyl-6,7-bis(methyloxy)-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate; 2,2'-{Pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis{1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium} bisbenzenesulfonateSynonyms
Products Containing Atracurium Besylate
비씨아트라쿠륨베실산염주사25밀리그램/2.5밀리리터(수출용)트라리움주(베실산아트라쿠륨)(수출용)[수출명: Newtrium Inj.]아크리움주사(아트라쿠륨베실산염)BESILATO DE ATRACURIO-HAMELN 10 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION EFGTRACRIUM 50 mg/5 ml (1 POUR CENT), solution injectable en ampouleTRACRIUM 250 mg/25 ml, solution injectableTRACRIUM 25 mg/2,5 ml (1 POUR CENT), solution injectable en ampouleATRACURIUM Pfizer 10 mg/mL, solution injectable/pour perfusionATRACURIUM KALCEKS 10 mg/mL, solution injectable/pour perfusionATRACURIUM HIKMA 10 mg/mL, solution injectable/pour perfusionVincuriumNotrixum
Page 1 of 4
Companies Selling Atracurium Besylate
(주
(주)비씨월드제약Republic of KoreaHF
HIKMA FARMACEUTICAPortugalAH
Aculife Healthcare Private LimitedIndiaGP
GLAND PHARMA LIMITEDIndiaSI
Sinoway Industrial Co.Ltd.ChinaNK
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.ChinaPage 1 of 4